Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases
In this Regenerative Medicine Editorial, learn why it is imperative to delineate a deeper and more critical understanding of the physiology of mesenchymal stem cells, including their survival time, ability to home into organs and tissues and donor-to-donor variability.
A functional characteristic of mesenchymal stem cells (MSCs) is their ability to differentiate into ectoderm, mesoderm and endoderm tissues including bone, neurons, muscles, hepatocytes, skin, among others. Nowadays, MSCs are valuable sources of therapeutics for regenerative medicine. In this Editorial, published in Regenerative Medicine, the authors explore how MSCs could be utilized in the treatment of degenerative bone diseases.
Shyam H, Singh SK, Kant R, Saxena SK. Mesenchymal stem cells in regenerative medicine: a new paradigm for degenerative bone diseases. Regen. Med. 12(2), 111–114 (2017)
Author for correspondence: email@example.com